Researchers report that cannabidiol attenuates the aggressiveness induced by social isolation. The study (“Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors”), based on a mouse model, was performed by scientists at the University of São Paulo’s Ribeirão Preto Medical School (FMRP-USP) in Brazil. The results are published in Progress in Neuro-Psychopharmacology and Biological Psychiatry.

“Long-term single housing increases aggressive behavior in mice, a condition named isolation-induced aggression or territorial aggression, which can be attenuated by anxiolytic, antidepressant, and antipsychotic drugs. Preclinical and clinical findings indicate that cannabidiol (CBD), a non-psychotomimetic compound from Cannabis sativa, has anxiolytic, antidepressant, and antipsychotic properties. Few studies, however, have investigated the effects of CBD on aggressive behaviors,” the investigators wrote.

“Here, we investigated whether CBD (5, 15, 30, and 60 mg/kg; i.p.) could attenuate social isolation-induced aggressive behavior in the resident-intruder test. Male Swiss mice (7–8 weeks) were single-housed for 10 days (resident mice) to induce aggressive behaviors, while conspecific mice of same sex and age (intruder mice) were group-housed. During the test, the intruder was placed into the resident’s home-cage and aggressive behaviors initiated by the resident, including the latency for the first attack, number of attacks, and total duration of aggressive encounters, were recorded. The involvement of 5-HT1A and CB1 receptors (CB1R) in the effects of CBD was also investigated.

“All tested CBD doses induced anti-aggressive effects, indicated by a decrease in the number of attacks. CBD, at intermediary doses (15 and 30 mg/kg), also increased latency to attack the intruder and decreased the duration of aggressive encounters. No CBD dose interfered with locomotor behavior. CBD anti-aggressive effects were attenuated by the 5-HT1A receptor antagonist WAY100635 (0.3 mg/kg) and the CB1 antagonist AM251 (1 mg/kg), suggesting that CBD decreases social isolation-induced aggressive behaviors through a mechanism associated with the activation of 5-HT1A and CB1 receptors.

“Also, CBD decreased c-Fos protein expression, a neuronal activity marker, in the lateral periaqueductal gray (lPAG) in social-isolated mice exposed to the resident-intruder test, indicating a potential involvement of this brain region in the drug effects. Taken together, our findings suggest that CBD may be therapeutically useful to treat aggressive behaviors that are usually associated with psychiatric disorders.”

“Our study shows that cannabidiol can inhibit aggressiveness and that it does so by facilitating the activation of two receptors: the 5-HT1A receptor, responsible for the effects of the neurotransmitter serotonin, and the CB1 receptor, responsible for the effects of endocannabinoids,” said Francisco Silveira Guimarães, PhD, professor at FMRP-USP and leader of the study.

Although it is extracted from marijuana, cannabidiol does not produce dependency or have psychotomimetic (psychosis-like) effects, Guimarães stressed. The component of marijuana responsible for these effects is tetrahydrocannabinol (THC). Cannabidiol actually inhibits some effects of THC.

“Cannabidiol has been studied in various contexts for the past 20 years, but very little research has been done into its effects on aggressive behavior,” added Guimarães.

Scientists at the University of São Paulo’s Center for Applied Research in Neuroscience (NAPNA-USP) also contributed to the new study, which was part of the São Paulo Research Foundation FAPESP funded Thematic Project “New perspectives in the use of drugs that modify atypical neurotransmitters in the treatment of neuropsychiatric disorders.”

Isolation-induced aggression is a classical behavioral model used in experiments, Guimarães explained.

“Isolation-induced aggression can be attenuated by the administration of anxiolytic, anti-depressant, or anti-psychotic drugs. Preclinical and clinical studies have shown that cannabidiol has these properties, so we decided to test its effect on induced aggressiveness,” he said. “We used a model known as the resident-intruder test, which induces aggressiveness in an animal kept in isolation for several days.”

To determine whether the effects of cannabidiol could alter the resident’s aggressive behavior, the researchers injected four groups, each comprising six to eight male mice, with different doses.

A fifth group acted as a control and was not given cannabidiol. The mice in this group displayed classical resident-intruder behavior. The first attacks by residents on intruders occurred two minutes after they were confronted on average. Between 20 and 25 attacks were recorded while the animals were in the same cage.

In the first group, resident mice received a cannabidiol dose equivalent to 5 mg/kg. Each male weighed 30–40 g. Attacks began approximately four minutes after intruders entered the cage, double the time taken for control mice to begin attacking intruders, and the number of attacks fell by half.

The second group received 15 mg/kg and behaved less aggressively than any of the others. Attacks began 11 minutes after the intruder’s arrival on average, and the number of attacks averaged only approximately five per cage.

The third and fourth groups received 30 mg/kg and 60 mg/kg, respectively, but these higher doses did not result in more intense inhibition of their aggressiveness. In contrast, attacks began sooner, and the number of attacks was also slightly higher.

“This reduction in the effect of cannabidiol at higher doses was expected from the results of other studies. In experiments to investigate its potential as an antidepressant, for example, higher doses led to lower effects after an initial gain. In our experiment, if we had tested 120 mg/kg on a group of mice, we might not have obtained any inhibition of the resident’s aggressiveness at all,” Guimarães said.

Blocking the effect

Because the scientists already knew that cannabidiol facilitates activation of the 5-HT1A serotonin receptor, they repeated the resident-intruder model in a second batch of experiments, but now administered different doses of the 5-HT1A receptor antagonist WAY100635.

The aim was to determine whether the anti-aggressive effect of cannabidiol could be canceled out or attenuated using WAY100635, as the researchers hypothesized.

“That was indeed the case. In resident mice given intermediate doses of WAY100635 before cannabidiol, the time it took for the first attack to occur after the intruder entered the cage was very close to the time taken by residents in the control group to attack. Control mice weren’t given the drug and began attacking intruders after about two minutes,” Guimarães said.

The same applied to the number of attacks. All mice given WAY100635 before cannabidiol, regardless of the dose, attacked intruders almost as many times as the controls.

Data from the literature and the laboratory itself suggest that cannabidiol also inhibits an enzyme that metabolizes the endocannabinoid anandamide. Endocannabinoids are neurotransmitters produced throughout the central nervous system, including the brain. Anandamide binds to type 1 cannabinoid receptors (CB1), which are also activated by THC, the main psychoactive cannabinoid in marijuana.

To determine whether this mechanism might also be involved in the anti-aggressive effect of cannabidiol, the researchers conducted a resident-intruder test using AM251, a CB1 receptor antagonist, combined with cannabidiol. The results were similar.

“The anti-aggressive effect of cannabidiol was attenuated by WAY100635, the 5-HT1A receptor antagonist, when dosed at 0.3 mg/kg, and by AM251, the CB1 receptor antagonist, at 1 mg/kg, suggesting that cannabidiol attenuates isolation-induced aggressive behavior by means of a mechanism associated with activation of 5-HT1A receptors and CB1 receptors,” according to Guimarães. “We don’t yet know how the 5-HT1A and CB1 receptors affect aggressiveness in mice, but the activation mechanisms involved appear to be different in each case.”

1 COMMENT

  1. If I had any illness or malady, cannabis (in any form) would be the last thing I’d put in my body. It poses a myriad of threats to anyone who uses it.

    The tobacco scandal will be pale in comparison as people realize that nearly everyone has been lying to them about pot, CBD oil, and the rest.

    Marijuana is now directly linked to schizophrenia, brain malformation, arrested genital development, arrested sperm production, male docility, emphysema, arrested development in multiple other areas, and a rare form of leukemia…

    CBD oil is now being linked to liver inflammation and liver cancer in test animals, and who knows what else they’ll find.

    When people realize that this garbage was pushed on them by greedy entrepreneurs and tax revenue hungry politicians, heads are going to roll – and God help those in the medical community who knew and SAID NOTHING !!!

This site uses Akismet to reduce spam. Learn how your comment data is processed.